Advancements in Rheumatology: The Role of IL-17 Inhibitors

This chapter delves into the progress made in rheumatology, especially regarding interleukin 17 inhibitors and their efficacy in patient treatment. It emphasizes the importance of methodical evaluation during treatment failures and discusses the promising potential of switching within this class of drugs to enhance patient outcomes.